 Patients undergoing surgery including surgery for hip fracture under spinal anaesthesia have not had access to goal directed fluid therapy because of the invasive nature of the existing monitoring technology such as oesophageal doppler. The availability of a non invasive cardiac monitoring device, the ClearsightTM, now makes goal directed fluid therapy a possibility for this group of patients. 